Allspring Global Investments
SWTX

Allspring Global Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Allspring Global Investments’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,711
Closed -$208K – 1795
2025
Q1 		$208K Buy
+4,711
New +$217K ﹤0.01% 1653
2024
Q4 		– Sell
-3,052
Closed -$97.8K – 2354
2024
Q3 		$97.8K Sell
3,052
-226
-7% -$8.44K ﹤0.01% 1782
2024
Q2 		$123K Buy
+3,278
New +$138K ﹤0.01% 1809
2023
Q2 		– Sell
-1,128
Closed -$29K – 2830
2023
Q1 		$29K Sell
1,128
-658
-37% -$19.2K ﹤0.01% 2436
2022
Q4 		$46.5K Sell
1,786
-40
-2% -$986 ﹤0.01% 2350
2022
Q3 		$52K Buy
1,826
+1,641
+887% +$47K ﹤0.01% 2338
2022
Q2 		$4K Sell
185
-14,569
-99% -$533K ﹤0.01% 2625
2022
Q1 		$832K Buy
14,754
+297
+2% +$17K ﹤0.01% 1994
2021
Q4 		$896K Buy
+14,457
New +$957K ﹤0.01% 2007

Other funds holding SWTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Allspring Global Investments's SWTX Position: Q2 2025 in Review

Allspring Global Investments sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 4,711 shares — an estimated $208K sold.

Allspring Global Investments first reported a position in SWTX in Q4 2021 and held it in 9 quarters. The position peaked at $896K in Q4 2021. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Allspring Global Investments reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 4,711 SpringWorks Therapeutics shares in Q2 2025, an estimated $208K.
  • Allspring Global Investments first reported a position in SpringWorks Therapeutics in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's SpringWorks Therapeutics position peaked at $896K in Q4 2021.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.